TABLE 1.
Patient characteristics.
| CA group (23 ears, n = 14) | Control group (34 ears, n = 20) | p-Value | |
| Age, mean [SD], year† | 74.1 [6.1] | 75.2 [5.2] | 0.48 |
| Sex‡ | 0.22 | ||
| Male | 12 ears, n = 8 | 22 ears, n = 13 | |
| Female | 11 ears, n = 6 | 12 ears, n = 7 | |
| HA experience, ears ‡ | 7 (30.4%) | 10 (29.4%) | 0.93 |
| HA side, n‡ | >0.99 | ||
| Unilateral | 5 (35.7%) | 6 (30%) | |
| Bilateral | 9 (64.3%) | 14 (70%) | |
| HA type, ears‡ | 0.37 | ||
| BTE | 0 (0%) | 2 (5.9%) | |
| RIC | 14 (60.9%) | 18 (52.9%) | |
| CIC | 8 (34.8%) | 14 (41.2%) | |
| ITC | 1 (4.3%) | 0 (0%) | |
| HA usage hours/day, ears‡ | 0.37 | ||
| 1 ≤ < 4 | 2 (8.7%) | 4 (11.8%) | |
| 4 ≤ < 8 | 11 (47.8%) | 10 (29.4%) | |
| 8 ≤ < 16 | 10 (43.5%) | 20 (58.8%) | |
| Medical history, ears | |||
| Hypertension | 8 (34.8%) | 4 (11.8%) | |
| Diabetes | 6 (26.1%) | 3 (8.8%) | |
| Cardiovascular disease | 4 (17.4%) | 1 (2.9%) |
BTE, behind the ear; CA, choline alfoscerate; CIC, completely in-canal; HA, hearing aid; ITC, in the canal; RIC, receiver in canal. †Independent t-test. ‡Chi-square test.